Skip to main content

AZN

Stock

AZN

Stock
Health Care
Drug Manufacturers - General

Performance overview

AZN Price
Price Chart

Forward-looking statistics

Beta
0.45
Risk
20.53%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

Company info

SectorHealth Care
IndustryDrug Manufacturers - General
Employees87K
Market cap$248.1B

Fundamentals

Enterprise value$134.7B
Revenue$55.0B
Revenue per employee
Profit margin14.14%
Debt to equity77.11

Security info

ExchangeNASDAQ
Type of shareADR
Earnings per share (EPS)$2.49
Dividend per share$2.10
Revenue per share$2.94
Avg trading volume (30 day)$297M
Avg trading volume (10 day)$321M
Put-call ratio

Macro factor sensitivity

Growth-0.9
Credit+1.9
Liquidity+0.5
Inflation-2.4
Commodities-0.4
Interest Rates-1.2

Valuation

Dividend yield3.02%
PEG Ratio12.65
Price to sales3.93
P/E Ratio12.65
Enterprise Value to Revenue2.45
Price to book2.62

Upcoming events

Next earnings dayJuly 29, 2025
Next dividend day
Ex. dividend dayFebruary 21, 2025

News

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.

Benzinga (July 12, 2025)
AstraZeneca Boasts Strong Oncology Portfolio: Can It Sustain Growth?

AstraZeneca  AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 41% of AstraZeneca's total revenues) rose 13% in the first quarter of 2025, generating $5.6 billion in sales.

Zacks Investment Research (July 8, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free